Protein kinase C in IL-2 signal transduction

Immunologic Research

Volumn 16, Issue 4, 1997, Pages 355-374

  Lu, Yin ^a   Durkin, Jon P ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Interleukin 2 (IL 2); Protein kinase C; Signal transduction

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN KINASE C;

CELLULAR IMMUNITY; HELPER CELL; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031457803     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786399     Document Type: Review

References (172)

1. Hamblin AS: Cytokines one by one; in Male D (ed): Cytokines and Cytokines Receptors. New York, Oxford University Press, 1993, pp 5-197.
2. Taniguchi,T, Minami Y: The IL-2/IL-2 receptor system: a current overview. Cell 1993;73:5-10.
3. Smith KA: Interleukin-2: inception, impact and implications. Science 1988;240:1169-1176.
4. Mier JW, Gallo RC: Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA 1980; 77:6134-6138.
5. Ruscetti FW, Gallo RC: Human Tlymphocyte growth factor: regulation of growth and function of T lymphocytes. Blood 1981;57:379-394.
6. Gillis S, Smith KA, Watson JD: Biochemical and biological characterization of lymphocyte regulatory-molecules. II. Purification of a class of rat and human lymphokines. J Immunol 1980;124:1954-1960.
7. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J: Structure and expression of a cloned cDNA for human interleukin-2. Nature 1983;302: 305-310.
8. Robb RJ, Kutny RM, Panieo M, Morris HR, Chowdhry V: Amino acid sequence and post-translational modification of human interleukin 2. Proc Natl Acad Sci USA 1984;81:6486-6490.
9. Wang A, Lu SD, Mark DF: Sitespecific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 1984;224:1431-1433.
10. Brandhuber BJ, Boone T, Kenney WC, McKay DB: Three-dimensional structure of interleukin-2. Science 1987;238:1707-1709.
11. Cohen FE, Kosen PA, Kuntz ID, Epstein LB, Ciardelli TL, Smith KA: Structure-activity studies of interleukin-2. Science 1986;234:349-352.
12. Holbrook NJ, Smith KA, Foranace AJ, Jr. Comeau CM, Wiskocil RL, Crabtree GR: T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc Natl Acad Sci USA 1984;81:1634-1638.
13. Shows T, Eddy R, Haley L, Byers M, Henry M, Fujita T, Matsui H, Taniguchi T: Interleukin 2 (IL-2) is assigned to human chromosome 4. Somatic Cell Mol Genet 1984;10: 315-318.
14. Benevenisto EN, Merrill JE: Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 1986;321: 610-613.
15. Stern JB, Smith KA: Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 1986;233:203-206.
16. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352:621-624.
17. Lotze MT, Grimm EA, Mazumder A, Strausser SA, Rosenberg SA: Lysis of fresh and cultured autologous tumor by lymphocytes cultured in T-cell growth factor. Cancer Res 1981;41:4420-4427.
18. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982;155:1823-1830.
19. Reisfeld RA, Gillies SD: Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy. J Clin Lab Anal 1996; 10:160-166.
20. Gillis S, Banker PE, Union NA, Smith KA: The in vitro generation and sustained culture of nude cytotoxic T-lymphocytes. J Exp Med 1979;149:1460-1467.
21. Farrar WL, Johnson HM, Farrar JJ: Regulation of the production of immune Interferon and cytotoxic T lymphocytes by interleukin 2. J. Immunol 1981;126:1120-1126.
22. Lenardo MJ: Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991;353: 858-861.
23. Nieto MA, Lopez-Rivas A: IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J Immunol 1989;143:4166-4172.
24. Rodriguez-Tarduchy G, Lopez-Rivas A: Phorbol ester inhibit apoptosis in IL-2-dependent T lymphocytes. Biochem Biophys Res Commun 1989;164:1069-1075.
25. Walker PR, Kwast-welfeld J, Gourdeau H, Leblanc J, Neugebauer W, Sikorska M: Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation and AP1. Exp Cell Res 1993;207:142-151.
26. Lu Y, Tremblay R, Jouishomme H, Chakravarthy B, Durkin JP: Evidence that the activation of an inactive pool of membrane-associated protein kinase C is linked to the IL-2-dependent survival of T lymphocytes. J Immunol 1994;153:1495-1504.
27. Kishi H, Inui S, Muraguchi A, Hirano T, Yamamura Y, Kishimoto T: Induction of IgG secretion in a human B cell clone with recombinant IL-2. J Immunol 1985;134: 3104-3110.
28. Mond JJ, Thompson CT, Finkelman FD, Farrar J, Schaefer M, Robb RJ: Affinity-purified interleukin-2 induces proliferation of large but not small B cells. Proc Natl Acad Sci USA 1985;82: 1518-1521.
29. Waldmann TA: The interleukin-2 receptor. J Biol Chem 1991;266: 2681-2684.
30. Minami Y, Kono T, Miyazaki T, Taniguchi T: The IL-2 receptor complex: Its structure, function, and target genes. Annu Rev Immunol 1993;11:245-267.
31. Leonard WJ, Depper JM, Kanehisa M, Kronke M, Peffer NJ, Svetlik PB, Sullivan M, Greene WC: Structure of the human interleukin-2 receptor gene. Science 1985;220:633-639.
32. Dukovich M, Wang Y, Thuy LB, Katz P, Cullen BR, Kehrl JH, Greene WC: A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature 1987;327:518-522.
33. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Nakamaura M, Sugamura K: Cloning of the γ chain of the human IL-2 receptor. Science 1992;257:379-382.
34. Cantrell DA, Smith KA: Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 1983;158:1895-1911.
35. Hatakeyama M, Mori H, Doi T, Taniquchi T: A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 1989;59:837-841.
36. Doi T, Hatakeyame M, Minamoto S, Kono T, Mori H, Taniguchi T: Human IL-2 receptor β chain allows transduction of IL-2-induced proliferation signal(s) in a murine cell line. Eur J Immunol 1989;19:2375-2381.
37. Farrar WL, Linnekin D, Brini AT, Kelvin DJ, Michiel DF: The interleukin-2 receptor complex: structure, gene regulation, and signal transduction; in Cambien JC (ed.): Ligands, Receptors, and Signal Transduction in Regulation of Lymphocyte Function. American Society of Microbiology, Washington, DC, 1990, pp 267-290.
38. Wang HM, Smith KA: The interleukin-2 receptor. Functional consequences of its molecular structure. J Exp Med 1987;166: 1055-1069.
39. Nelson BH, Lord JD, Greenberg PD: Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 1994;369:333-336.
40. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling. Nature 1994;369:330-336.
41. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 1990;51:203-212.
42. Sharon M, Gnarra JR, Leonard WJ: A 100-kilodalton protein is associated with the murine interleukin2 receptor: Biochemical evidence . Proc Natl Acad Sci USA 1990;87:4869-4873.
43. Saragovi H, Malek TR: Evidence for additional subunits associated to the mouse interleukin 2 receptor p55/p75 complex. Proc Natl Acad Sci USA 1990;87:11-15.
44. Colamonici OR, Neckers LM, Rosolen A: Putative γ-subunit of the IL-2 receptor is detected in low, intermediate, and high affinity IL-2 receptor-bearing cells. J Immunol 1990;145:155-160.
45. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ: A new cytokine receptor superfamily. TIBS 1990;15:265-270.
46. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K: Cytokine receptors and signal transduction. Annu Rev Immunol 1992;10:295-306.
47. Miyazaki T, Maruyama M, Yamada G, Hatakeyama M, Taniguchi T: The integrity of the conserved 'WS motif common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J 1991;10:3191-3199.
48. Itoh N, Yonehara S, Schreurs J, Gorman DM, Maruyama K, Ishii A, Yahara I, Arai KI, Miyajima A: Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science 1990;247: 324-327.
49. Goodwin RG, Friend D, Ziegler SK, March CJ, Namen AE, Park LS: Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990;60:941-951.
50. Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB: Administration of an antiinterleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med 1985;162:358-362.
51. Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB: Anti-interleukin 2 receptor antibody suppresses murine diabtic insulitis and lupus nephritis. J Immunol 1988;140:59-61.
52. Lemaistre CF, Meneghetti C, Rosenblum M, Reuben JH, Parker K: Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood 1992;79:2547-2554.
53. Boitard C, Timsit J, Assan R, Mogenet A, Debussche,X: Treatment of recent-onset type I (insulin-dependent)diabetes millitus with DAB486 IL-2, a toxin conjugate aiming at activated T lymphocytes. Diabetologia 1992;35[Suppl 1]:A218.
54. Moreland LW, Sewell KL, Trentham DE, Bucy RP, Sullivan WF, Schrohenloher RE, Shmerling RH, Parker KC, Swartz WG, Woodworth TG, Koopman WJ: Interleukin-2 diphtheria fusion protein (DAB-486IL-2) in refractory rheumatoid arthritis. A doubleblind, placebo-controlled trial with open-label extension. Arthritis Rheum 1995;38:1177-1186.
55. Hunter T, Cooper JA: Proteintyrosine kinases. Annu Rev Biochem 1985;54:897-905.
56. Hunter T: Oncoprotein networks. Cell 1997;88:333-346.
57. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 1991;88:11,349-11,353.
58. Miura O, D'Andrea A, Kabat D, Ihle JN: Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol 1991; 11:4895-4904.
59. Koyasu S, Tojo A, Miyajima A, Akiyama T, Kasuga M, Urabe A, Schreurs J, Arai K, Takaku F, Yahara I: Interleukin 3-specific tyrosine phosphorylation of a membrane glycoprotein of Mr 150000 in multi-factor-dependent myeloid cell lines. EMBO J 1987;6:3979-3984.
60. Mills GB, May C, McGill M, Fung M, Baker M, Sutherland R, Green WC: Interleukin 2-induced tyrosine phosphorylation. J Biol Chem 1990;265:3561-3567.
61. Uckun FM, Tuel-Ahlgren L, Obuz V, Smith R, Dibirdik I, Hanson M, Langlie MC, Bedbetter JA: Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human feta thymocytes. Proc Natl Acad Sci USA 1991;88:6323-6327.
62. Ferris DK, Willette-Brown J, Ortaldo JR, Farrar WL: IL-2 regulation of tyrosine kinase activity is mediated through the p70-75b-subunit of the IL-2 receptor. J Immunol 1989;143:870-878.
63. Ohtsuka T, Kaziro Y, Satoh T: Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP. Biochim Biophy Acta 1996;1310:223-232.
64. lck: identification of novel intermolecular association. Science 1991; 252:1523-1528.
65. lck. Proc Natl Acad Sci USA 1991;88:1996-2000.
66. Torigoe T, Saragovi HU, Reed JC: Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line. Proc Natl Acad Sei USA 1992;89:2674-2678.
67. lyn with the interleukin 2 receptor: Implications for redundancy and pleiotropism in cytokine signal transduction. Proc Natl Acad Sci USA 1993;90:4201-4205.
68. Merida I, Pratt JC, Gaulto GN: Regulation of interleukin 2 dependent growth responses by glycosylphosphatidylinositol molecules. Proc Natl Acad Sci USA 1990;87:9421-9425.
69. Eardley DD, Koshland ME: Glycosylphosphatidylinositol: a candidate system for interleukin-2 signal transduction. Science 1991;251:78-81.
70. Kanazawa T, Keeler ML, Varticovski L: Serine-rich region of the IL-2 receptor beta-chain is required for activation of phosphatidylinositol 3-kinase. Cell Immunol 1994;156:378-388.
71. Gomez J, Martinez AC, Garcia A, Rebollo A: Association of phosphatidylinositol 3 kinase to protein kinase C ζ during interleukin-2 stimulation. Eur J Immunol 1996; 26:1781-1787.
72. Medema RH, Bos JL: The role of p21 ras in receptor tyrosine kinase signaling. Crit Rev Oncog 1993; 4:615-661.
73. Margolis, B., Skolnik, E. Y: Activation of Ras by receptor tyrosine kinases. J Am Soc Nephrol 1994;5:1288-1299.
74. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras in signal transduction pathways from interleukin-2, interleukin-3, and granulocyte-macrophage colony stimulation factor, but not from interleukin-4. Proc Natl Acad Sci USA 1991;88:3314-3318.
75. Satoh T, Minami Y, Kono T, Yamada K, Kawahara A,Taniguchi T, Kaziro Y: Interleukin 2-induced activation of ras requires two domains of interleukin 2 receptor β subunit, the essential region for growth stimulation and Lck-binding domain. J Biol Chem 1992;267: 25,423-25,427.
76. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T: IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 1992;70:57-67.
77. Zmuidzinas A, Mamon HJ, Roberts TM, Smith KA: Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CDS-stimulated primary human T cells. Mol Cell Biol 1991;11: 2794-2799.
78. Turner B, Rapp U, App H, Greene M, Dobashi K, Reed J: Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in T-cell line. Proc Natl Acad Sci USA 1991;88: 1227-1231.
79. Carroll MP, Clark-Lewis I, Rapp UR, May WS: Interleukin-3 and granulocyte-macrophage colony-stimulating factor mediate rapid phosphorylation and activation of cytosolic c-raf. J Biol Chem 1990;265:19,812-19,816.
80. lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol 1992;12:4521-4530.
81. Ihle JN, Witthuhn BA, Quelle FW, Yamanoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 1995;13:369-382.
82. Inoue M, Kishimoto A, Takai Y, Nishizuka Y: Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 1977;252:7610-7616.
83. Takai Y, Kishimoto A, Inoue M, Nishizuka Y: Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 1977;252:7603-7609.
84. Bell RM, Burns DJ: Lipid activation of protein kinase C. J Biol Chem 1991;266:4661-4664.
85. Hug H, Sarre TF: Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291:329-343.
86. Dekker LV, Parker PJ: Protein kinase C - a question of specificity. Trends Biochem Sci 1994; 19:73-77.
87. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
88. Nakadate T, Jeng AY, Blumberg PM: Effect of phospholipid on substrate phosphorylation by a catalytic fragment of protein kinase C. J Biol Chem 1987; 262:11,507-11,513.
89. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, Water-field MD, Francke U, Ullrich A: Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 1986;233:859-866.
90. House C, Kemp B: Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 1987;238:1726-1728.
91. Ono Y, Fujii T, Igarashi K, Kuno T, Tanaka C, Kikkawa U, Nishizuka Y: Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci 1989;86:4868-4871.
92. Taylor SS, Radzio-Andzelm E: Three protein kinase structures define a common motif. Structure 1994;2:345-355.
93. Bazzi MD, Nelsestuen GL: Role of substrate in determining the phospholipid specificity of protein kinase C activation. Biochemistry 1987;26:5002-5008.
94. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
95. Sando JJ, Maurer MC, Bolen EJ, Grisham CM: Role of cofactors in protein kinase C activation. Cell Signal 1992;4:595-602.
96. Bazzi MD, Nelsestuen GL: Protein kinase C interaction with calcium: a phospholipid-dependent process. Biochemistry 1990;29:7624-7630.
97. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y: Protein kinase C ζ subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci USA 1989;86:3099-3103.
98. Ohno S, Akita Y, Konno Y, Imajoh S, Suzuki K: A novel phorbol ester receptor / protein kinase, nPKC distantly related to the protein kinase C family. Cell 1988;53: 731-741.
99. Liyanage M, Frith D, Livneh E, Stabel S: Protein kinase C group B members PKC-delta, -epsilon, -zeta and PKC-L (eta). Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J 1992;283:781-787.
100. Bazzi MD, Nelsestuen GL: Role of substrate in determining the phospholipid specificity of protein kinase C activation. Biochemistry 1987;26:5002-5008.
101. Herget T, Oehrlein SA, Pappin DJ, Rozengurt E, Parker PJ: The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. Eur J Biochem 1995;233:448-457.
102. 2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 1983; 301:621-623.
103. Farrar WL, Anderson WB: Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature 1985;315:233-235.
104. Stabel S, Parker PJ: Protein kinase C. Pharmacol Ther 1991;51:71-82.
105. Dawson RMC: Studies on the enzymic hydrolysis of monophos-phoinositide by phospholipase preparations from P. notatum and ox pancreas. Biochim Biophys Acta 1959;33:68-77.
106. Jarpe MB, Leach KL, Raben DM: -Thrombin-induced nuclear sn-1,2-diacylglycerols are derived from phosphatidyl-choline hydrolysis in cultured fibroblasts. Biochemistry 1994;33:526-534.
107. Boni LT, Rando RR: The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols. J Biol Chem 1985;260:10,819-10,824.
108. Slater SJ, Ho C, Kelly MB, Larkin JD, Taddeo FJ, Yeager MD, Stubbs CD: Protein kinase Cα contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities. J Biol Chem 1996;271:4627-4631.
109. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661-668.
110. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumorpromoting phorbol esters. J Biol Chem 1982;257:7847-7851.
111. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 1979;254:3692-3695.
112. Halsey DL, Girard PR, Kuo JF, Blackshear PJ: Protein kinase C in fibroblasts: characteristics of its intracellular location during growth and after exposure to phorbol esters and other mitogens. J Biol Chem 1987;262:2234-2243.
113. Pelech SL, Meier KE, Crebs EG: Rapid microassay for protein kinase C translocation in Swiss 3T3 cells. Biochemistry 1986;25: 8348-8353.
114. Mukaida N, Yagisawa H, Kawai T, Kasahara T: The role of protein kinase C activation in signal transmission by interleukin 2. Biochem Biophys Res Commun 1988;154:187-193.
115. Pelech SL, Paddon HB, Charest DL, Federsppiel BS: IL-3-induced activation of protein kinases in the mast cell/megakaryocyte R6-XE.4 line. J Immunol 1990;144: 1759-1766.
116. Pelech SL, Charest DL, Howard SL, Paddon HB, Salari H: Protein kinase C activation by platelet-activating factor is independent of enzyme translocation. Biochim Biophys Acta 1990;1051:100-107.
117. Chaikin E, Ziltener HJ, Razin E: Protein kinase C plays an inhibitory role in interleukin 3- and interleukine 4-mediated mast cell proliferation. J Biol Chem 1990; 265:22,109-22,116.
118. Tang EK, Houslay MD: Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity. Biochem J 1992;283:341-346.
119. Chakravarthy BR, Tremblay R, Macdonald P, Krsmanovic V, Whitfield JF, Durkin JP: The activation of inactive membraneassociated protein kinase C is associated with DMSO-induced erythroleukemia cell differentiation. Biochim Biophys Acta, 1992;1136:83-90.
120. Chakravarthy BR, Whitfield JF, Durkin JP: Inactive membrane protein kinase Cs: a possible target for receptor signaling. Biochem J 1994;304:809-816.
121. Chakravarthy BR, Wong J, Durkin JP: Evidence that the modulation of membrane-associated protein kinase C activity by an endogenous inhibitor plays a role in NIE-115 murine neuroblatoma cell differentiation. J Neurochem 1995;65:1569-1579.
122. Durkin JP, Chakravarthy BR,Tremblay R, Macdonald P, Jouishomme H, Whitfield JF, Biquard JM, Krsmanovic V: Evidence that a novel human differentiation-inhibiting protein (DIP) blocks DMSO-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C. Cancer Res 1992;52:6329-6334.
123. Bazzi MD, Nelsestuen GL: Constitutive activity of membrane-inserted protein kinase C. Biochem Biophys Res Comm 1988;152:336-343.
124. 2+ and phorbol esters. Nature 1985;317:546-549.
125. May WS, Jr, Sahyoun N, Wolf M, Cuatrecasas P: Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes. Nature 1985;317:549-551.
126. Hannun YA, Loomis CR Bell RM: Activation of protein kinase C by Triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J Biol Chem 1985;260:10,039-10,044.
127. Chakravarthy B, Bussey A, Whitfield JF, Sikorska M, Williams RE, Durkin JP: The direct measurement of protein kinase C in isolated membranes using selective peptide substrate. Anal Biochem 1991; 196:144-150.
128. Durkin JP, Tremblay R, Blosser J, Charkravarthy B, Mealing G, Morley P, Song D: An early loss in membrane protein kinase C activity precedes the delayed death of primary cortical neurons by excitatory amino acids. J Neurochem 1995;66:951-962.
129. Asaoka Y, Yoshida K, Oka M, Shinomura T, Hishima H, Matsushima S, Nishizuka Y: The signalinduced phospholipid degradation cascade and protein kinase C activation; in Sato R, Bock GR, (eds): Wiley, Interactions Among Cell Signaling Systems (Ciba Foundation symposium 164)Chichester, UK, 1992, pp. 50-65.
130. Rester M, Simonson MS, Mene P, Sedor JR: Interleukin-1 generates transmembrane signals from phospholipids through novel pathways on cultured rat mesangial cells. J Clin Invest 1989;83:718-724.
131. 2+-dependent protein kinase. Science 1984;224:622-624.
132. Lester DS, Collin C, Etcheberrigaray R, Alkon DL: Arachidonic acid diacylglycerol act synergistically to activate protein kinase in vitro and in vivo. Biochem Biophys Res Comm 1991;179:1522-1528.
133. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM: Oleic acid-induced mitogenic signaling in vascular smooth muscle cells: A role for protein kinase C. Circ Res 1996;79:611-618.
134. Ikeuchi Y, Nishizaki T, Matsuoka T, Sumikawa K: Arachidonic acid potentiates Ach receptor currents by protein kinase C activation but not by receptor phosphorylation. Biochem Biophys Res Comm 1996;221:716-721.
135. Bell RL, Kennerley DA, Stanford N, Jajerus PW: Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979;76:3238-3241.
136. 2 activity specific for phosphatidic acid: a possible mechanism for the production of arachidonic acid in platelets. J Biol Chem 1981;256: 5399-5403.
137. Needleman P, Turk J, Jakschilc BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
138. Asaoka Y, Nakamura S, Yoshida K, Nishizuka Y: Protein kinase C, calcium and phospholipid degradation. Trens Biochem Sci 1992; 17:414-427.
139. Williams RE, Chakravarthy BR, Sikorska M, Whitfield JF, Durkin JP: A protein kinase C substrate peptide derived from MARCKS protein, in Smith JA, Rivier JE (eds.): Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium. Leiden, Germany, Escom, 1992, pp 923,924.
140. 160 of MARCKS in rat brain. Biochem Biophys Res Comm 1993;190:236-241.
141. Orr JW, Keranen LM, Newton AC: Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol. J Biol Chem 1992;267:15,263-15,268.
142. Farrar WL, Cleveland JL, Beckner SK, Bonvini E, Evans ST: Biochemical and molecular events associated with interleukin-2 regulation of lymphocyte proliferation. Immunol Rev 1986;92:49-65.
143. Evans SW, Farrar WL: Interleukin 2 and diacyglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. J Biol Chem 1987; 262:4624-4630.
144. Beckner SK, Farrar WL: Inhibition of adenylate cyclase by IL-2 in human T lymphocytes is mediated by protein kinase C. Biochem Biophys Res Comm 1987;145: 176-182.
145. Beckner SK, Farrar WL: Interleukin 2 modulation of adelynate cyclase. Potential role of protein kinase C. J Biol Chem 1986;261:3043-3049.
146. + exchange and phospholipid turnover. Immunol Rev 1987;95:59-75.
147. Mills GB, Cheung RK, Grinstein S, Gelfand EW: Interleukin 2-induced lymphocyte proliferation is independent of increases in cytosolic-free calcium concentrations. J Immunol 1985;34: 2431-2435.
148. Mills GB, Stewart DJ, Mellors A, Gelfand EW: Interleukin 2 does not induce phosphatidylinositol hydrolysis in activated T cells. J Immunol 1986;136:3019-3024.
149. Mills GB, Girard P, Grinstein S, Gelfand EW: Interleukin-2 induces proliferation of T lymphocyte mutants lacking protein kinase C. Cell 1988;55:91-100.
150. Valge VE, Wong JGP, Datlof BM, Sinskey AJ, Rao A: Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 1988;55:101-112.
151. Redondo JM, Lopez-Rivas A, Vila V, Cragoe EJ, Fresno M: The role of protein kinase C in T lymphocyte proliferation. J Biol Chem 1988;263:17,467-17,470.
152. Jouishomme H, Whitfield JF, Chakravarthy B, Durkin JP, Gagnon L, Isaacs RJ, MacLean S, Neugebauer W, Willick G, Rixon RH: The protein kinase C-activation domain of the parathyroid hormone. Endocrinology 1992;130:53-58.
153. Evans SW, Beckner SK, Farrar WL: Stimulation of specific GTP binding and hydrolysis activities in lymphocytes membrane by interleukin-2. Nature 1987;325: 166-168.
154. Rhee SG, Choi KD: Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem 1992;267:12,393-12,396.
155. Exton JH: Role of G proteins in activation of phosphoinositide phospholipase C. Adv Second Messenger Phosphoprotein Res 1993;28:65-72.
156. Schutze S, Berkovic D, Tomsing O, Unger C, Kronke M: Tumor necrosis factor induces rapid production of 1,2-diacylglycerol by a phosphatidylcholine-specific phospholipase C. J Exp Med 1991;174:975-988.
157. Exton JH: Signaling through phosphatidylcholine breakdown. J Biol Chem 1990;265:1-4.
158. Rosoff PM, Savage N, Dinarello CA: Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 1988,54:73-79.
159. Durino V, Nip L, Pelech SL: Interleukin 3 stimulates phosphatidylcholine turnover in a mast/megakaryocyte cell line. Biochem Biophys Res Comm 1989;164:804-810.
160. Imamura, K., Dianoux, A., Nakamura, T., Kufe, D: Colony-stimulating factor 1 activates protein kinase C in human monocytes. EMBO J 1990;9:2423-2429.
161. Pfeffer LM, Strulovici B, Saltiel AR: Interferon-alpha selectively activates the β isoform of protein kinase C through phosphatidylcholine hydrolysis. Proc Natl Acad Sci USA 1990;87:6537-6541.
162. Magolda RL, Ripka WC, Galbraith W, Johnson PR, Rudnick MS: Novel synthesis of potent site-specific phospholipase A2 inhibitors; in Bailey JM (ed): Prostaglandins, Leukotriens, and Lipoxins. New York, Plenum, 1985, pp 669-675.
163. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem 1994;269: 15,625-15,630.
164. Greene WC, Robb RJ, Svetlik PB, Rusk CM, Depper JM, Leonard WJ: Stable expression of cDNA encoding the human interleukin-2 receptor in eukaryotic cells. J Exp Med 1985;162:363-368
165. Tsudo M, Kozak RW, Goldman CK, Waldmann TA: Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci USA 1987;84:4215-4218.
166. Tsudo M, Kozak RW, Goldman CK, Waldmann TA: Demonstration of a non-Tac peptide that binds interleuin 2: a potential participant in a multichain interleuin 2 receptor complex. Proc Natl Acad Sci USA 1986;83:9694-9698.
167. Teshigawara K, Wang HM, Kato K, Smith KA: Interleuin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med 1987;165:223-228.
168. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
169. Osada S, Mizuno K, Saido TC, Suzuki K, KurokiT, Ohno S: A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle. Mol Cell Biol 1992;12:3930-3938.
170. Baier G, Telford D, Giampa L, Coggeshall K. M., Baier-Bitterlich G, Isakov N, Altman A: Molecular cloning and characterization of PKCθ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 1993;268:4997-5004.
171. 1,2, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 1993;268:24,296-24,302.
172. G1, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem 1994;269:12,677-12,683.